RxDoctor Payments Data

Dawn Dolan

Physician Assistant · Amherst, NYNPI 1871549048

Payments from drug & device makers

$3,031in general payments, 2019–2025

Across 155 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$335
  • Lilly USA, LLC$302
  • Novo Nordisk$266
  • Boehringer Ingelheim$238
  • Pfizer$196
  • Astellas Pharma US Inc$183
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$3,031100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,031 in reported general payments places this provider in the 85th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$13,061
Medicare patients
86
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$42,839
OzempicSemaglutide34$39,511
TrulicityDulaglutide25$29,239
JanuviaSitagliptin Phosphate11$9,004
Levothyroxine Sodium181$3,030
Atorvastatin Calcium144$2,341
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,083
SynthroidLevothyroxine Sodium31$2,031
Rosuvastatin Calcium108$1,785
Albuterol Sulfate HfaAlbuterol Sulfate57$1,692
Ezetimibe20$1,567
Fluticasone Propionate89$1,427
Lisinopril141$1,402
Amlodipine Besylate146$1,401
Metformin Hcl ErMetformin Hcl59$1,231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$196$42,83945 claims
Novo NordiskOzempic$266$39,51134 claims
Lilly USA, LLCTrulicity$302$29,23925 claims
MerckJanuvia$98$9,00411 claims
AbbVieSynthroid$73$2,03131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Amherst

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →